UnitedHealth Group Incorporated Income Charts

72 quarters of history · ending 2026-03-31 · SEC EDGAR

Source:10-K · 10-Q

Revenue, Gross Profit, Operating Income & Net Income

Margin (%)

Operating Expenses

Income Breakdown

Revenue↑+2.0% +$2.15B
$111.72B
SG&A↑+13.2% +$1.80B
$15.39B
D&A↓-3.0% -$32M
$1.03B
Operating Income↓-1.4% -$129M
$8.99B
EBITDA↓-1.6% -$161M
$10.02B
Interest Expense↓-4.3% -$43M
$955M
Other Income/Expense↓-380.0% -$57M
$-72M
Pretax Income↓-1.8% -$143M
$7.96B
Tax Provision↓-9.2% -$150M
$1.48B
Net Income↓-0.2% -$12M
$6.28B
Operating Margin↓-0.3pts
8.0%
Net Margin↓-0.1pts
5.6%
Effective Tax Rate↓-1.5pts
18.6%
Deferred Tax Liabilities↓-26.6% -$1.04B
$2.86B
ETR (Continuing Operations)↓-11.2pts
12.9%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.7pts
1.0%
ETR Foreign Differential (pp)↓-3.5pts
-5.3%
Operating Lease CostNEW↑+31.3% +$200M
$840M
Remaining Performance ObligationNEW↓-11.3% -$1.40B
$11.00B
Revenue YoY Variation↓-7.8pts
2.0%
Income YoY Variation↓-16.4pts
-1.4%
Revenue QoQ Variation↓-10.0pts
-1.3%
Income QoQ Variation↑+2248.5pts
2265.8%
No segment data available for this ticker. Source: quarterchart.com.

UnitedHealth Group Incorporated — SEC R-Report Segment ScorecardNEW

One card per operating segment. KPIs read the latest disclosed value (issuer-precomputed margin and YoY %, not recomputed client-side). Sparkline shows the 3-period revenue trend. Source: SEC EDGAR R-reports.

Optumrx

Revenue (latest)$57.68B
Margin12.5%
YoY+8.0%

3-period revenue trend

Optumhealth

Revenue (latest)$36.87B
Margin-0.8%
YoY-6.0%

3-period revenue trend

Optuminsight

Revenue (latest)$6.37B
Margin41.2%
YoY-4.1%

3-period revenue trend

Unitedhealthcare

Revenue (latest)$342.73B
Margin2.7%
YoY+15.9%

3-period revenue trend

Per-Segment Profit Margin TrendNEW

Segment profit margin % over time — issuer-precomputed (read directly from the R-report; not recomputed client-side). Y-axis pinned to [-10, 100] so loss-making segments stay visible alongside high-margin headline lines.

UnitedHealth Group Incorporated — Customer & Supplier ConcentrationNEW

Major-customer and supplier-side disclosures sourced from srt:MajorCustomersAxis dimensional XBRL. Coverage is ~44% of the S&P 500 (sparser than other panels) but high-value when present — a 20%+ single-counterparty exposure is a headline business risk required to be disclosed in 10-K MD&A under Reg S-K Item 101.Largest single-counterparty concentration this period: 44%.

Customer-Side Concentration

End-customer dependence — single-customer % of revenue. NVDA Customer 1 = 25%, AVGO Major Customer 1 = 32%.

As of 2025-12-31 · 3 rows

CounterpartyKindConcentrationRevenue / Spend
CMScustomer
44.0%
External Customerscustomer$342.73B
Intercustomer